Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies

Clinical trial NCT02214160 · COMPLETED

Trial details

NCT number: NCT02214160
Sponsor: Ultragenyx Pharmaceutical Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carnitine Palmitoyltransferase (CPT I or CPT II) Deficiency Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency Long-chain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency Trifunctional Protein (TFP) Deficiency Carnitine-acylcarnitine Translocase (CACT) Deficiency

Start date: 2014-12-09
Primary completion: 2020-12-03
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.